TRX818
TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
393.21
Molecular Formula
C16H11FNNa2O5P
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1256037-58-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1459733-01 0.02 mg (E-Coli)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details 
MBS1459733-02 0.02 mg (Yeast)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details MBS1459733-03 0.1 mg (E-Coli)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details 
MBS1459733-04 0.1 mg (Yeast)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details MBS1459733-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details 
MBS1459733-06 0.02 mg (Mammalian-Cell)
Recombinant Staphylococcus epidermidis Pyrimidine-nucleoside phosphorylase (pdp)
Ask
View Details